Daniel M Berney

Summary

Publications

  1. ncbi request reprint Major shifts in the treatment and prognosis of prostate cancer due to changes in pathological diagnosis and grading
    Daniel M Berney
    Department of Histopathology, St Bartholomew s Hospital, Queen Mary University of London, London, UK
    BJU Int 100:1240-4. 2007
  2. ncbi request reprint Malignant germ cell tumours in the elderly: a histopathological review of 50 cases in men aged 60 years or over
    Daniel M Berney
    Department of Histopathology, Barts, The London School of Medicine and Dentistry, St Bartholomew s Hospital, West Smithfield, London, UK
    Mod Pathol 21:54-9. 2008
  3. doi request reprint DNA topoisomerase I and IIalpha expression in penile carcinomas: assessing potential tumour chemosensitivity
    Daniel M Berney
    The Orchid Tissue Laboratory, Barts and the London School of Medicine and Dentistry, Queen Mary, University of London, London, UK
    BJU Int 102:1040-4. 2008
  4. doi request reprint The retinoblastoma protein/p16 INK4A pathway but not p53 is disrupted by human papillomavirus in penile squamous cell carcinoma
    Elzbieta Stankiewicz
    Queen Mary University of London, Centre for Molecular Oncology and Imaging, Barts and the London School of Medicine and Dentistry, London, UK
    Histopathology 58:433-9. 2011
  5. doi request reprint The prognostic value of Ki-67 expression in penile squamous cell carcinoma
    Elzbieta Stankiewicz
    Department of Molecular Oncology, Barts Cancer Institute, London, UK
    J Clin Pathol 65:534-7. 2012
  6. pmc An improved prognostic model for stage T1a and T1b prostate cancer by assessments of cancer extent
    Ramzi Rajab
    Centre for Molecular Oncology and Imaging, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK
    Mod Pathol 24:58-63. 2011
  7. doi request reprint High-resolution genome-wide copy-number analysis suggests a monoclonal origin of multifocal prostate cancer
    Lara K Boyd
    Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK
    Genes Chromosomes Cancer 51:579-89. 2012
  8. pmc Prognostic value of an RNA expression signature derived from cell cycle proliferation genes in patients with prostate cancer: a retrospective study
    Jack Cuzick
    Cancer Research UK Centre of Epidemiology, Mathematics and Statistics, Wolfson Institute of Preventive Medicine, St Bartholomew s Medical School, Queen Mary University of London, London, UK
    Lancet Oncol 12:245-55. 2011
  9. pmc The association of CCND1 overexpression and cisplatin resistance in testicular germ cell tumors and other cancers
    Elodie E Noel
    Medical Oncology Centre, Cancer Institute, Barts and London School of Medicine and Dentistry, Queen Mary, University of London, Charterhouse Square, London EC1M 6BQ, UK
    Am J Pathol 176:2607-15. 2010
  10. doi request reprint p53 immunochemistry is an independent prognostic marker for outcome in conservatively treated prostate cancer
    Sak Kudahetti
    The Orchid Tissue Laboratory, Barts and the London School of Medicine and Dentistry, Centre for Molecular Oncology, London
    BJU Int 104:20-4. 2009

Collaborators

Detail Information

Publications24

  1. ncbi request reprint Major shifts in the treatment and prognosis of prostate cancer due to changes in pathological diagnosis and grading
    Daniel M Berney
    Department of Histopathology, St Bartholomew s Hospital, Queen Mary University of London, London, UK
    BJU Int 100:1240-4. 2007
    ..To examine data on the changes in the accuracy of the diagnosis of prostate cancer and of Gleason grading in the modern era...
  2. ncbi request reprint Malignant germ cell tumours in the elderly: a histopathological review of 50 cases in men aged 60 years or over
    Daniel M Berney
    Department of Histopathology, Barts, The London School of Medicine and Dentistry, St Bartholomew s Hospital, West Smithfield, London, UK
    Mod Pathol 21:54-9. 2008
    ..We conclude that germ cell tumours, in man aged 60 years or above, present at a later stage than in younger men, and although most are seminomas, non-seminomatous tumours may occur with a wide spectrum of morphology...
  3. doi request reprint DNA topoisomerase I and IIalpha expression in penile carcinomas: assessing potential tumour chemosensitivity
    Daniel M Berney
    The Orchid Tissue Laboratory, Barts and the London School of Medicine and Dentistry, Queen Mary, University of London, London, UK
    BJU Int 102:1040-4. 2008
    ....
  4. doi request reprint The retinoblastoma protein/p16 INK4A pathway but not p53 is disrupted by human papillomavirus in penile squamous cell carcinoma
    Elzbieta Stankiewicz
    Queen Mary University of London, Centre for Molecular Oncology and Imaging, Barts and the London School of Medicine and Dentistry, London, UK
    Histopathology 58:433-9. 2011
    ..The aim was to determine the extent of HPV infection in different histological subtypes of PSCC and its impact on the expression of key cell-cycle proteins: p53, p21, p16(INK4A) and retinoblastoma (RB) protein...
  5. doi request reprint The prognostic value of Ki-67 expression in penile squamous cell carcinoma
    Elzbieta Stankiewicz
    Department of Molecular Oncology, Barts Cancer Institute, London, UK
    J Clin Pathol 65:534-7. 2012
    ..To determine whether Ki-67 immunoexpression in penile squamous cell carcinoma (PSCC) has a prognostic value and correlates with lymph node metastasis, human papillomavirus (HPV) infection and patient survival...
  6. pmc An improved prognostic model for stage T1a and T1b prostate cancer by assessments of cancer extent
    Ramzi Rajab
    Centre for Molecular Oncology and Imaging, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK
    Mod Pathol 24:58-63. 2011
    ..Staging by a four-group subdivision would substantially improve prognostication in patients with early stage disease and also may help to refine management decisions in patients who would do well with conservative treatments...
  7. doi request reprint High-resolution genome-wide copy-number analysis suggests a monoclonal origin of multifocal prostate cancer
    Lara K Boyd
    Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK
    Genes Chromosomes Cancer 51:579-89. 2012
    ..These findings, which demonstrate the monoclonal origin of multifocal prostate cancer, should significantly enhance our understanding of prostate carcinogenesis...
  8. pmc Prognostic value of an RNA expression signature derived from cell cycle proliferation genes in patients with prostate cancer: a retrospective study
    Jack Cuzick
    Cancer Research UK Centre of Epidemiology, Mathematics and Statistics, Wolfson Institute of Preventive Medicine, St Bartholomew s Medical School, Queen Mary University of London, London, UK
    Lancet Oncol 12:245-55. 2011
    ..We assessed the prognostic value of a predefined cell cycle progression (CCP) score in two cohorts of patients with prostate cancer...
  9. pmc The association of CCND1 overexpression and cisplatin resistance in testicular germ cell tumors and other cancers
    Elodie E Noel
    Medical Oncology Centre, Cancer Institute, Barts and London School of Medicine and Dentistry, Queen Mary, University of London, Charterhouse Square, London EC1M 6BQ, UK
    Am J Pathol 176:2607-15. 2010
    ..CCND1 could be potentially used as a marker for treatment stratification and as a molecular target to improve the treatment of platinum-resistant tumors...
  10. doi request reprint p53 immunochemistry is an independent prognostic marker for outcome in conservatively treated prostate cancer
    Sak Kudahetti
    The Orchid Tissue Laboratory, Barts and the London School of Medicine and Dentistry, Centre for Molecular Oncology, London
    BJU Int 104:20-4. 2009
    ..03) and overall survival (HR 1.57, 95% CI 1.21-2.05, P = 0.001). CONCLUSIONS We conclude that p53 may have a role in the future assessment of newly diagnosed prostate cancer, as it significantly adds to the current prognostic model...
  11. doi request reprint Immunohistochemistry for p16, but not Rb or p21, is an independent predictor of prognosis in conservatively treated, clinically localised prostate cancer
    Sakunthala C Kudahetti
    Centre for Molecular Oncology and Imaging, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, UK
    Pathology 42:519-23. 2010
    ....
  12. pmc Alternative HER/PTEN/Akt pathway activation in HPV positive and negative penile carcinomas
    Elzbieta Stankiewicz
    Centre for Molecular Oncology and Imaging, Institute of Cancer, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom
    PLoS ONE 6:e17517. 2011
    ..We investigated HER family receptors and phosphatase and tension homolog (PTEN) in HPV-positive and negative PSCC and its impact on Akt activation using immunohistochemistry and fluorescent in situ hybridisation (FISH)...
  13. ncbi request reprint The association between intratubular seminoma and invasive germ cell tumors
    Daniel M Berney
    Department of Histopathology and Morbid Anatomy, St Bartholomew s and the Royal London School of Medicine and Dentistry, Queen Mary University of London, West Smithfield, UK
    Hum Pathol 37:458-61. 2006
    ..However, because it is not specifically associated with seminoma, we suggest that it is not useful to discriminate this lesion from IGCNU and that it merely represents an advanced form of IGCNU on the way to invasive malignancy...
  14. pmc Absolute quantitation of DNA methylation of 28 candidate genes in prostate cancer using pyrosequencing
    Natasa Vasiljevic
    Cancer Research UK Centre for Epidemiology, Mathematics and Statistics, Wolfson Institute of Preventive Medicine, Barts and the London School of Dentistry and Medicine, Queen Mary University of London, London, UK
    Dis Markers 30:151-61. 2011
    ....
  15. doi request reprint HPV infection and immunochemical detection of cell-cycle markers in verrucous carcinoma of the penis
    Elzbieta Stankiewicz
    Centre for Molecular Oncology and Imaging, Barts and the London School of Medicine and Dentistry, London, UK
    Mod Pathol 22:1160-8. 2009
    ....
  16. doi request reprint Pathology in prostate research: optimizing tissue quality
    Daniel M Berney
    Department of Molecular Oncology and Imaging, Institute of Cancer, Queen Mary University of London, London, UK
    Acta Oncol 50:53-5. 2011
    ..The collection of tissue from the prostate gland for research creates unique challenges in the identification of cancer and in preserving pathological material...
  17. pmc Androgen-induced TMPRSS2:ERG fusion in nonmalignant prostate epithelial cells
    Nuria Coll Bastus
    Centre of Molecular Oncology and Imaging, Institute of Cancer, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK
    Cancer Res 70:9544-8. 2010
    ..This study demonstrates that fusions can be induced prior to malignant transformation and generation of the fusion is associated with both gene proximity and loss of the ability to prevent double-strand breaks...
  18. pmc Distinct genomic alterations in prostate cancers in Chinese and Western populations suggest alternative pathways of prostate carcinogenesis
    Xueying Mao
    Molecular Oncology and Imaging Centre, Medical Oncology Centre, Institute of Cancer, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom
    Cancer Res 70:5207-12. 2010
    ..Our findings suggest that tumors arise in Western and Chinese populations by alternative pathogenetic mechanisms...
  19. doi request reprint Pathology in prostate research: optimizing the pathological data
    Daniel M Berney
    Department of Molecular Oncology and Imaging, Institute of Cancer, Queen Mary University of London, London, UK
    Acta Oncol 50:49-52. 2011
    ..Conclusion. Appropriate utilization of such pathological material will produce improved cohorts in which it will be possible to test new biomarkers with increased rigor...
  20. doi request reprint International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 4: seminal vesicles and lymph nodes
    Daniel M Berney
    Department of Molecular Oncology and Imaging, St Bartholomew s Hospital Queen Mary University of London, London, UK
    Mod Pathol 24:39-47. 2011
    ..These consensus decisions will hopefully clarify the difficult areas of pathological assessment in radical prostatectomy evaluation and improve the concordance of research series to allow more accurate assessment of patient prognosis...
  21. doi request reprint The reasons behind variation in Gleason grading of prostatic biopsies: areas of agreement and misconception among 266 European pathologists
    Daniel M Berney
    Queen Mary University of London, London, UK
    Histopathology 64:405-11. 2014
    ..The Gleason scoring system underwent revision at the International Society of Urological Pathology (ISUP) conference in 2005. It is not known how uropathologists have interpreted its recommendations...
  22. ncbi request reprint The frequency and distribution of intratubular trophoblast in association with germ cell tumors of the testis
    Daniel M Berney
    Department of Histopathology and Morbid Anatomy, Bartholomew s and the Royal London School of Medicine and Dentistry, Queen Mary University of London, St Bartholomew s Hospital, West Smithfield, London EC1A 7BE, UK
    Am J Surg Pathol 29:1300-3. 2005
    ..Differentiation toward trophoblastic elements in GCTs may occur at an earlier stage of their pathogenesis than has been previously recognized...
  23. pmc Local progression among men with conservatively treated localized prostate cancer: results from the Transatlantic Prostate Group
    James A Eastham
    Department of Urology, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Eur Urol 53:347-54. 2008
    ..Men with clinically detected localized prostate cancer treated without curative intent are at risk of complications from local tumor growth. We investigated rates of local progression and need for local therapy among such men...
  24. ncbi request reprint Adult leydig cell tumors of the testis caused by germline fumarate hydratase mutations
    Luis G Carvajal-Carmona
    Laboratory of Molecular and Population Genetics, London Research Institute, Cancer Research UK, London WC2A 3PX, United Kingdom
    J Clin Endocrinol Metab 91:3071-5. 2006
    ..We identified an LCT in an affected individual from a kindred with hereditary leiomyomatosis and renal cell cancer (HLRCC) and a germline fumarate hydratase (FH) mutation (N64T)...